Selective apoptosis of natural killer-cell tumours by l-asparaginase.
about
Diagnosis and management of extranodal NK/T cell lymphoma nasal type.Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients.Extranodal NK/T-cell lymphoma nasal type: efficacy of pegaspargase. Report of two patients from the United Sates and review of literature.Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibitionConsolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphomaL-Asparaginase delivered by Salmonella typhimurium suppresses solid tumorsL-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphomaProgress in understanding and managing natural killer-cell malignancies.Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinomaL-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphomaExtranodal NK / T-cell lymphoma, nasal type: new staging system and treatment strategies.High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies.Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.Risk stratification in extranodal natural killer/T-cell lymphoma.Treatment of Aggressive NK-Cell Leukemia: A Case Report and Review of the Literature.The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysis.A critical review on properties and applications of microbial l-asparaginases.Clinical study of l-asparaginase in the treatment of extranodal NK/T-cell lymphoma, nasal type.Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population.A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines.Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell linesTreatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy.Expression of asparagine synthetase predicts in vitro response to L-asparaginase in canine lymphoid cell lines.The diagnosis and management of NK/T-cell lymphomas.L-Asparaginase for newly diagnosed extra-nodal NK/T-cell lymphoma: systematic review and meta-analysis.Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma.CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.Management of advanced NK/T-cell lymphoma.Retrospective study of modified SMILE chemotherapy for advanced-stage, relapsed, or refractory extranodal natural killer (NK)/T cell lymphoma, nasal type.Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma.Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma.An Epstein-Barr virus positive natural killer lymphoma xenograft derived for drug testing.Successful disease control with L-asparaginase monotherapy for aggressive natural killer cell leukemia with severe hepatic failure.Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia.Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-cell lymphoma: A multicenter retrospective study.
P2860
Q30249309-73A896BB-DF3F-4EB9-BC84-BF6677CA0F26Q33415901-09D360AC-02C4-488A-B6E5-0AD76690D722Q33620726-EBBE2072-F0C0-45AD-B2F8-617D830B0C37Q34571639-5E9CC23D-8F00-4F06-9CF0-71F120F8F622Q36760583-370148EE-BF21-4F03-B37F-A3A68A4265CDQ36838520-2F12DB43-85B3-4277-8E72-734FDB28CF57Q36954142-F9A9990F-454E-4C30-BA00-B4DEDB21D428Q36960580-F4AA2ECE-E1AF-4B41-8826-E4E6D9CC32E0Q37003403-FBDC0D7C-0DD3-4A63-9868-CE04E7C6FCACQ37243101-7B0BC863-C7FC-4551-A99D-E2FDA6D8650EQ37243949-FF313D61-0901-4DF5-802C-B76B20372E33Q37301747-BC755275-E808-4E94-A188-0647CE874033Q37376566-F6232301-4907-4223-808C-11133AAD0A5EQ37598368-9C8DC101-3755-44CB-B555-D5ABBA850378Q37600612-5B629D9A-AE33-4970-A5C1-14FAE7602BD1Q37626051-F696818E-F88D-4FBF-9F95-52D84069E65BQ37788238-905C6081-19A6-41A2-8554-6192B9120CF5Q38039427-74213092-33B7-4C13-8A0C-2B1A68C4C075Q38124057-BF79449C-B972-4B34-8AE4-5D327480AE34Q38417141-EC8C97A2-906C-40E8-B97E-221397A39E55Q38433407-EB7D2868-8B59-4A0A-BDE9-1015E1BF72D9Q38779524-F6F747CF-BC9C-4569-BB9D-520F5DA36183Q38835470-94716E05-21B8-42DA-AB08-2F031DDB0B1BQ38838632-C6604AC2-0BAF-402F-BA47-9728640D0C92Q38915906-6DA99AB3-E2D9-4550-A046-EBC78660767AQ39038225-90711B1E-8541-4DF3-B66F-BD40217549FEQ39096462-EDC92D6E-4FFE-404E-A4E2-D239C0A8F8B4Q39243241-E86607E4-24DF-4B46-92D6-DE1F18D77F66Q39377852-E6D2A9D6-B0F0-4972-AC5C-FDF00D4AF16EQ40441775-0229984D-917E-4248-AC94-BDC3BD026FB0Q41085075-7D49AB21-96C1-4321-9434-D5C2B447BEDBQ42212820-F8A804DC-CF8F-45DD-81FE-48F28BDFB8C4Q42267458-8F55BA18-D8BB-45A3-A505-DCE39E725F66Q43755217-FE016255-1FFE-4321-96C5-785334B3B71AQ44453896-3FFB81B9-50BE-43C2-9ADA-043D3A7F7222Q44784473-801822BE-1A21-4CA9-9C2E-C7E5C6CC4AE6Q45802969-5A02B670-1808-48D5-ADC7-121356E5C1DCQ46738245-96D36383-59FF-4F5E-BFD8-F08DEDFDF42FQ48166631-4D3D6AFF-63F2-42EC-886C-14B986099E93Q48196748-8A64A5B6-B118-4986-A6A3-30D30BD6DBFD
P2860
Selective apoptosis of natural killer-cell tumours by l-asparaginase.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Selective apoptosis of natural killer-cell tumours by l-asparaginase.
@en
type
label
Selective apoptosis of natural killer-cell tumours by l-asparaginase.
@en
prefLabel
Selective apoptosis of natural killer-cell tumours by l-asparaginase.
@en
P2093
P2860
P1476
Selective apoptosis of natural killer-cell tumours by l-asparaginase
@en
P2093
Kazuo Oshimi
Koichi Sugimoto
Kouichi Mukai
Makoto Sasaki
Motoki Egashira
Sheldon M Schuster
P2860
P304
P356
10.1111/J.1365-2141.2005.05694.X
P407
P577
2005-09-01T00:00:00Z